Panbela Therapeutics, Inc. Convertible Notes Payable, Current
Panbela Therapeutics, Inc. had Convertible Notes Payable, Current of $1.08 million as of 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2020-03-24
- 2019-03-31: Convertible Notes Payable, Current $1.08M.
- 2018-12-31: Convertible Notes Payable, Current $64.00K.
- 2018-09-30: Convertible Notes Payable, Current $25.00K.
- 2018-06-30: Convertible Notes Payable, Current $25.00K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2019-03-31 | $1.08M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $64.00K 10-K · filed 2020-03-24 |
| 2018-09-30 | $25.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $25.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $1.96M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $1.52M 10-K · filed 2019-03-22 |
| 2016-12-31 | $2.73M 10-K · filed 2018-03-21 |